- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/62 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho- position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
Patent holdings for IPC class C07C 235/62
Total number of patents in this class: 17
10-year publication summary
1
|
1
|
0
|
0
|
1
|
0
|
1
|
3
|
0
|
2
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
F. Hoffmann-La Roche AG | 7958 |
3 |
The Regents of the University of California | 18943 |
2 |
AstraZeneca AB | 3042 |
2 |
Mitsubishi Tanabe Pharma Corporation | 579 |
2 |
Pfizer Inc. | 3322 |
1 |
Syngenta Participations AG | 4970 |
1 |
Canopy Growth Corporation | 270 |
1 |
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 67 |
1 |
Isagro S.p.A. | 51 |
1 |
Neuropore Therapies, Inc. | 39 |
1 |
Orion Corporation | 554 |
1 |
Sanofi | 3836 |
1 |
Other owners | 0 |